Arsenic Trioxide Promotes Tumor Progression by Inducing the Formation of PGCCs and Embryonic Hemoglobin in Colon Cancer Cells

Arsenic trioxide (ATO) has been used to treat acute promyelocytic leukemia. However, it is not effective in treating solid tumors such as colorectal cancer. We have previously reported that polyploid giant cancer cells (PGCCs) exhibiting the characteristics of cancer stem cells can be generated by v...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zugui, Zheng, Minying, Zhang, Hao, Yang, Xiaohui, Fan, Linlin, Fu, Fangmei, Fu, Junjie, Niu, Rui, Yan, Man, Zhang, Shiwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523995/
https://www.ncbi.nlm.nih.gov/pubmed/34676163
http://dx.doi.org/10.3389/fonc.2021.720814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523995/
https://www.ncbi.nlm.nih.gov/pubmed/34676163
http://dx.doi.org/10.3389/fonc.2021.720814

Ejemplares similares